Histone deacetylase as target for antiprotozoal agents
US6428983B1 · kind B1 · utility
9Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 1999 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | Apr 22, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Histone deacetylase inhibition provides a target for identifying potential antiprotozoal compounds. Histone deacetylase inhibitors are useful as therapeutic agents against protozoal infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.